Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates.
drug repositioning
immunomodulation
pancreatic ductal adenocarcinoma
repurposed drugs
tumor microenvironment
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
05 Aug 2021
05 Aug 2021
Historique:
received:
30
06
2021
revised:
26
07
2021
accepted:
02
08
2021
entrez:
27
8
2021
pubmed:
28
8
2021
medline:
28
8
2021
Statut:
epublish
Résumé
Pancreatic cancer (PC) is one of the deadliest malignancies worldwide, since patients rarely display symptoms until an advanced and unresectable stage of the disease. Current chemotherapy options are unsatisfactory and there is an urgent need for more effective and less toxic drugs to improve the dismal PC therapy. Repurposing of non-oncology drugs in PC treatment represents a very promising therapeutic option and different compounds are currently being considered as candidates for repurposing in the treatment of this tumor. In this review, we provide an update on some of the most promising FDA-approved, non-oncology, repurposed drug candidates that show prominent clinical and preclinical data in pancreatic cancer. We also focus on proposed mechanisms of action and known molecular targets that they modulate in PC. Furthermore, we provide an explorative bioinformatic analysis, which suggests that some of the PC repurposed drug candidates have additional, unexplored, oncology-relevant targets. Finally, we discuss recent developments regarding the immunomodulatory role displayed by some of these drugs, which may expand their potential application in synergy with approved anticancer immunomodulatory agents that are mostly ineffective as single agents in PC.
Identifiants
pubmed: 34439102
pii: cancers13163946
doi: 10.3390/cancers13163946
pmc: PMC8394389
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : Ministry of Education, University and Research (MIUR), Progetti di Ricerca di Interesse Nazionale (PRIN)
ID : 2017EKMFTN_005
Références
Diabetes Care. 2019 Sep;42(9):1675-1683
pubmed: 31227582
Oncotarget. 2014 Nov 15;5(21):10503-17
pubmed: 25361177
Nat Med. 2019 Apr;25(4):628-640
pubmed: 30833752
J Cell Biochem. 2019 Mar;120(3):4333-4341
pubmed: 30260036
World J Gastroenterol. 2005 Nov 7;11(41):6489-94
pubmed: 16425421
Life Sci. 2021 Apr 1;270:119118
pubmed: 33548284
BMJ Open. 2020 Sep 30;10(9):e040406
pubmed: 32998931
J Am Coll Surg. 2007 May;204(5):996-1005; discussion 1005-6
pubmed: 17481528
J Clin Invest. 2010 Jul;120(7):2355-69
pubmed: 20577053
Sci Rep. 2016 May 18;6:26165
pubmed: 27189859
Lancet Oncol. 2009 Jan;10(1):61-71
pubmed: 19111246
Mol Cancer Res. 2014 Jun;12(6):924-39
pubmed: 24667985
Mol Ther Oncolytics. 2020 Sep 02;19:19-32
pubmed: 33024816
Biomedicines. 2021 Mar 09;9(3):
pubmed: 33803470
Signal Transduct Target Ther. 2020 Jul 2;5(1):113
pubmed: 32616710
Cancer Cell. 2014 Jun 16;25(6):719-34
pubmed: 24856586
HPB (Oxford). 2009 Nov;11(7):606-11
pubmed: 20495714
Curr Med Chem. 2018;25(22):2595-2607
pubmed: 28403788
Nat Rev Cancer. 2006 Mar;6(3):240-8
pubmed: 16498446
Pharmacology. 2019;103(5-6):250-256
pubmed: 30731453
Gastroenterology. 2009 Jan;136(1):177-186.e1
pubmed: 18992743
ACS Appl Mater Interfaces. 2016 Feb 10;8(5):3438-45
pubmed: 26759926
Radiother Oncol. 2019 Mar;132:55-62
pubmed: 30825970
BMC Cancer. 2019 Feb 4;19(1):121
pubmed: 30717707
Int J Cancer. 2007 Feb 15;120(4):743-52
pubmed: 17131308
J Clin Invest. 2001 Oct;108(8):1167-74
pubmed: 11602624
Nat Rev Cancer. 2008 Dec;8(12):915-28
pubmed: 19029956
Cancer Chemother Pharmacol. 2010 Feb;65(3):597-605
pubmed: 19904538
Clin Microbiol Rev. 2016 Jul;29(3):695-747
pubmed: 27281742
Sci Rep. 2020 Feb 13;10(1):2574
pubmed: 32054977
BMC Cancer. 2013 May 10;13:235
pubmed: 23663483
Eur J Cancer. 2014 May;50(7):1382-90
pubmed: 24503026
Medicine (Baltimore). 2017 Mar;96(10):e6229
pubmed: 28272215
Semin Cancer Biol. 2021 Jan;68:186-191
pubmed: 31982510
Diabetes Care. 2012 Feb;35(2):299-304
pubmed: 22266734
Cancer Biol Ther. 2010 Jul 1;10(1):19-29
pubmed: 20424515
Anticancer Res. 2018 Jun;38(6):3493-3500
pubmed: 29848702
Front Oncol. 2020 Jan 21;9:1550
pubmed: 32039023
Front Immunol. 2018 Feb 06;9:164
pubmed: 29479349
Pharmacol Rev. 2012 Jul;64(3):520-39
pubmed: 22544865
Ann Surg Oncol. 2015 Dec;22(13):4402-10
pubmed: 25905586
J Gastrointest Surg. 2016 Sep;20(9):1572-80
pubmed: 27255657
Front Cell Dev Biol. 2019 Jul 05;7:86
pubmed: 31334229
Cancer Res. 2005 Sep 15;65(18):8256-65
pubmed: 16166302
J Clin Endocrinol Metab. 2005 Oct;90(10):5663-71
pubmed: 16030158
Cancer Cell. 2010 Apr 13;17(4):388-99
pubmed: 20385363
Cancer Chemother Pharmacol. 2017 Nov;80(5):1005-1012
pubmed: 28980060
Parkinsons Dis. 2021 Jan 04;2021:2603641
pubmed: 33489083
Psychooncology. 2010 Dec;19(12):1313-20
pubmed: 20119937
Dig Dis Sci. 2018 Nov;63(11):2840-2852
pubmed: 30159732
Oncotarget. 2014 Nov 30;5(22):11029-37
pubmed: 25415228
ACS Nano. 2017 Sep 26;11(9):8668-8678
pubmed: 28806504
J Biol Chem. 2020 Dec 4;295(49):16678-16690
pubmed: 32978257
Surg Open Sci. 2019 Jul 03;1(2):56-63
pubmed: 33981979
Anticancer Res. 2009 Oct;29(10):3995-4003
pubmed: 19846942
Nature. 2016 Jun 14;534(7607):314-6
pubmed: 27306171
Oncology. 2001;61(1):42-6
pubmed: 11474247
Oncol Lett. 2017 Aug;14(2):1240-1246
pubmed: 28789339
Cancers (Basel). 2014 Nov 06;6(4):2243-58
pubmed: 25383481
Ecancermedicalscience. 2017 Nov 23;11:781
pubmed: 29225688
PLoS One. 2015 May 08;10(5):e0125779
pubmed: 25955843
Cancer Res. 2005 Sep 1;65(17):7902-10
pubmed: 16140961
Nat Med. 2017 Jan;23(1):120-127
pubmed: 27869804
Drugs R D. 2015 Mar;15(1):13-20
pubmed: 25698589
Gastroenterology. 2020 Apr;158(5):1433-1449.e27
pubmed: 31786131
Oncologist. 2014 Jun;19(6):637-8
pubmed: 24821822
Lab Invest. 2002 Jun;82(6):747-56
pubmed: 12065685
PLoS One. 2016 Oct 28;11(10):e0165586
pubmed: 27792755
Cancer Res. 2019 Sep 1;79(17):4453-4465
pubmed: 31289132
Acta Biochim Pol. 2019 Dec 13;66(4):521-531
pubmed: 31834689
Oncol Lett. 2016 May;11(5):3265-3272
pubmed: 27123101
Cancers (Basel). 2019 Dec 17;11(12):
pubmed: 31861153
Nat Med. 2019 Apr;25(4):620-627
pubmed: 30833748
Cancer Chemother Pharmacol. 2021 Feb;87(2):159-172
pubmed: 33426580
Med Sci (Basel). 2017 Jun 19;5(2):
pubmed: 29099030
Eur J Pharmacol. 2019 Aug 5;856:172402
pubmed: 31108054
Cancer Discov. 2016 Aug;6(8):852-69
pubmed: 27246539
Int J Oncol. 2020 Mar;56(3):651-684
pubmed: 32124955
Nat Rev Drug Discov. 2019 Jan;18(1):41-58
pubmed: 30310233
Int J Biol Sci. 2014 Jun 10;10(7):654-63
pubmed: 25013375
Mol Oncol. 2015 Apr;9(4):889-905
pubmed: 25637283
Neurology. 2006 Nov 28;67(10):1860-2
pubmed: 17035676
Nat Commun. 2013;4:2516
pubmed: 24084631
Cancer Lett. 2017 Nov 28;409:9-19
pubmed: 28864067
Nat Rev Drug Discov. 2019 Jan;18(1):1-2
pubmed: 29880920
Mol Oncol. 2018 Apr;12(4):529-544
pubmed: 29453806
N Engl J Med. 2008 Jun 12;358(24):2649-51
pubmed: 18550886
Oncotarget. 2016 Nov 22;7(47):77825-77837
pubmed: 27788481
Cancer Res. 2014 Jun 1;74(11):2913-21
pubmed: 24840647
Clin Cancer Res. 2017 Oct 1;23(19):5959-5969
pubmed: 28600474
Clin Cancer Res. 2020 Jul 1;26(13):3126-3134
pubmed: 32156749
Oncology. 2015;88(4):208-13
pubmed: 25502607
JAMA Oncol. 2019 Jul 01;5(7):1020-1027
pubmed: 31145418
Anticancer Drugs. 2009 Jul;20(6):477-82
pubmed: 19387337
Curr Top Med Chem. 2016;16(29):3385-3403
pubmed: 27291902
Oncotarget. 2015 Mar 10;6(7):4569-84
pubmed: 25625193
BMC Cancer. 2021 May 7;21(1):510
pubmed: 33957901
Pancreatology. 2019 Mar;19(2):377-382
pubmed: 30733163
Nat Rev Drug Discov. 2012 Mar 01;11(3):191-200
pubmed: 22378269
Pancreas. 2013 Oct;42(7):1054-9
pubmed: 24051965
PLoS Med. 2010 Apr 20;7(4):e1000267
pubmed: 20422030
Cancer Res. 2005 Sep 15;65(18):8433-41
pubmed: 16166322
Am J Surg. 1993 Jan;165(1):61-6; discussion 66-7
pubmed: 8380314
J Natl Cancer Inst. 2010 Dec 15;102(24):1855-73
pubmed: 21088277
J Clin Oncol. 2020 Jan 1;38(1):1-10
pubmed: 31682550
Clin Cancer Res. 2015 Mar 1;21(5):1215-24
pubmed: 25552484
Invest New Drugs. 1993 Feb;11(1):29-37
pubmed: 8349433
Cancers (Basel). 2019 Apr 28;11(5):
pubmed: 31035321
Lancet. 2006 Mar 11;367(9513):825-31
pubmed: 16530576
Oncogene. 2007 May 14;26(22):3203-13
pubmed: 17496916
Oncol Lett. 2017 Sep;14(3):2587-2597
pubmed: 28927025
Nature. 2003 Oct 23;425(6960):851-6
pubmed: 14520413
Mol Cancer Ther. 2014 Jul;13(7):1758-71
pubmed: 24785258
Oncotarget. 2016 Jul 5;7(27):41825-41842
pubmed: 27259232
Drug Discov Today. 2019 Oct;24(10):2076-2085
pubmed: 31238113
Pancreas. 2014 Aug;43(6):886-90
pubmed: 24717824
Drugs Aging. 2000 Mar;16(3):227-50
pubmed: 10803861
J Clin Oncol. 2008 Jun 1;26(16):2699-706
pubmed: 18509182
Nat Rev Mol Cell Biol. 2012 Mar 22;13(4):251-62
pubmed: 22436748
Oncol Rep. 2018 Apr;39(4):1573-1582
pubmed: 29484419
J Hum Genet. 2005;50(4):159-167
pubmed: 15824892
Ann Surg. 2014 Nov;260(5):900-7; discussion 907-8
pubmed: 25379860
Ecancermedicalscience. 2015 Aug 11;9:563
pubmed: 26316884
Drug Discov Today. 2016 Jul;21(7):1189-95
pubmed: 27240777
PLoS One. 2016 Jan 13;11(1):e0147113
pubmed: 26760500
Nat Rev Cancer. 2010 Nov;10(11):745-59
pubmed: 20966920
J Exp Clin Cancer Res. 2018 Sep 21;37(1):236
pubmed: 30241558
Cancer Res. 2009 Aug 15;69(16):6539-45
pubmed: 19679549
Pediatrics. 2019 Jan;143(1):
pubmed: 30584062
Drugs. 2001;61 Suppl 1:27-37
pubmed: 11219548
Eur J Endocrinol. 2021 Jan;184(1):E1-E4
pubmed: 33112276
Br J Cancer. 2021 Jan;124(2):333-344
pubmed: 32929194
HIV Clin Trials. 2008 Sep-Oct;9(5):324-36
pubmed: 18977721
N Engl J Med. 2019 Jul 25;381(4):317-327
pubmed: 31157963
Cells. 2016 Apr 06;5(2):
pubmed: 27058560
PLoS One. 2015 Jun 18;10(6):e0130277
pubmed: 26086472
NPJ Precis Oncol. 2019 Jun 3;3:16
pubmed: 31231686
Nucleic Acids Res. 2019 Jul 2;47(W1):W357-W364
pubmed: 31106366
J Clin Invest. 2014 Apr;124(4):1525-36
pubmed: 24614108
Oncol Lett. 2018 Feb;15(2):1728-1736
pubmed: 29434868
Ann Oncol. 2013 Aug;24(8):1972-9
pubmed: 23670093
Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):2909-14
pubmed: 21282607
Eur J Cancer. 2020 Nov;140:130-139
pubmed: 33091717
Genes Dev. 2011 Apr 1;25(7):717-29
pubmed: 21406549
Anticancer Agents Med Chem. 2017;17(12):1617-1623
pubmed: 28270076
J Pharmacol Exp Ther. 1999 Oct;291(1):367-73
pubmed: 10490926
Nature. 2020 May;581(7806):100-105
pubmed: 32376951
Cancer Res. 2013 Apr 1;73(7):2345-56
pubmed: 23348422
Cancer Res. 2004 Oct 15;64(20):7426-31
pubmed: 15492266
Int J Mol Sci. 2017 Jun 22;18(7):
pubmed: 28640192
Anticancer Drugs. 2020 Jun;31(5):431-439
pubmed: 32044795
Semin Cancer Biol. 2021 Jan;68:8-20
pubmed: 31550502
Am J Cancer Res. 2021 Mar 01;11(3):884-897
pubmed: 33791161
JAMA Oncol. 2019 Jul 01;5(7):993-998
pubmed: 31120501
RSC Adv. 2019 Jun 25;9(34):19690-19698
pubmed: 35519380
PLoS One. 2012;7(2):e31384
pubmed: 22348081
Toxicol Appl Pharmacol. 2013 Dec 15;273(3):477-83
pubmed: 24060341
Gastroenterology. 2017 May;152(6):1492-1506.e24
pubmed: 28126348
Eur J Pharm Sci. 2014 Jul 16;58:13-9
pubmed: 24613900
Pancreatology. 2016 May-Jun;16(3):423-33
pubmed: 27083074
Clin Cancer Res. 2010 Feb 1;16(3):912-23
pubmed: 20103665
Pharmaceuticals (Basel). 2021 Apr 17;14(4):
pubmed: 33920661
Life Sci. 2012 Dec 17;91(25-26):1317-22
pubmed: 23063941
JOP. 2014 Mar 10;15(2):189-97
pubmed: 24618445
Nat Rev Drug Discov. 2012 Jan;11(1):3
pubmed: 22329019
Sci Rep. 2020 Mar 9;10(1):4363
pubmed: 32152409
Arch Biochem Biophys. 1988 Apr;262(1):307-13
pubmed: 3281589
Am J Clin Oncol. 2019 Oct;42(10):755-760
pubmed: 31513018
Am J Cancer Res. 2019 Jun 01;9(6):1266-1281
pubmed: 31285958
Clin Evid. 2003 Jun;(9):1349-71
pubmed: 15366179
Clin Cancer Res. 2013 Jul 1;19(13):3508-19
pubmed: 23695170
J Transl Med. 2020 May 20;18(1):207
pubmed: 32434573
Oncotarget. 2017 Apr 11;8(15):25242-25250
pubmed: 28445955
Oncotarget. 2017 May 26;8(33):55478-55488
pubmed: 28903435
Pharmaceuticals (Basel). 2014 Jan 09;7(1):46-57
pubmed: 24451403
Lancet Oncol. 2015 Jul;16(7):839-47
pubmed: 26067687
Radiother Oncol. 2016 May;119(2):306-11
pubmed: 27117177
Medicine (Baltimore). 2020 Sep 11;99(37):e21687
pubmed: 32925714
Tumour Biol. 2017 Jun;39(6):1010428317705517
pubmed: 28618969
Cancers (Basel). 2020 Jul 18;12(7):
pubmed: 32708493
Sci Rep. 2017 Jul 19;7(1):5825
pubmed: 28724893
Cancer Lett. 2021 Mar 31;501:210-223
pubmed: 33212158
Theranostics. 2019 Aug 14;9(20):6002-6018
pubmed: 31534533
Oncotarget. 2014 Sep 30;5(18):8161-72
pubmed: 25327558
Clin Cancer Res. 2016 Mar 1;22(5):1076-85
pubmed: 26459175
EMBO Mol Med. 2020 Aug 7;12(8):e12476
pubmed: 32715647
Proc Natl Acad Sci U S A. 2014 Jul 29;111(30):E3091-100
pubmed: 25024225
Oncotarget. 2016 Jan 19;7(3):3548-58
pubmed: 26657290
Cell Rep. 2015 Mar 17;10(10):1681-1691
pubmed: 25772356
Pancreas. 2009 Jan;38(1):94-100
pubmed: 19106745
Microbiol Mol Biol Rev. 2001 Jun;65(2):232-60 ; second page, table of contents
pubmed: 11381101
Autophagy. 2018;14(8):1435-1455
pubmed: 29940786
J Biol Chem. 2014 Oct 3;289(40):27692-701
pubmed: 25143389
Biochim Biophys Acta. 2016 Apr;1865(2):111-22
pubmed: 26794395
Nat Rev Cancer. 2020 Feb;20(2):74-88
pubmed: 31686003
Cancer Cell. 2018 Jan 8;33(1):75-90.e7
pubmed: 29249692
Semin Cancer Biol. 2021 Jan;68:279-290
pubmed: 32437876
J Hepatol. 2002 Dec;37(6):797-805
pubmed: 12445421
Int J Biochem Cell Biol. 2003 Jun;35(6):838-46
pubmed: 12676170
Gastroenterology. 2016 Dec;151(6):1218-1231
pubmed: 27578530
Front Oncol. 2021 Feb 11;10:619317
pubmed: 33643917
J Enzyme Inhib Med Chem. 2020 Dec;35(1):1331-1344
pubmed: 32588672
Mol Cell. 2018 Aug 16;71(4):606-620.e7
pubmed: 30118680
Nature. 2020 Dec;588(7839):693-698
pubmed: 33177715
Biochem Biophys Res Commun. 2015 Sep 11;465(1):41-6
pubmed: 26225747
Diabetes Care. 2012 Dec;35(12):2665-73
pubmed: 23173135
Invest New Drugs. 2006 May;24(3):255-60
pubmed: 16205854
Cancer Epidemiol Biomarkers Prev. 2020 Jan;29(1):169-175
pubmed: 31685560
Gastroenterol Res Pract. 2012;2012:781765
pubmed: 23125850
Clin Cancer Res. 2012 May 15;18(10):2905-12
pubmed: 22465831
Mol Cancer Ther. 2013 Dec;12(12):2792-803
pubmed: 24126434
Pediatr Blood Cancer. 2014 Sep;61(9):1598-602
pubmed: 24753394
J Clin Oncol. 2016 Jun 1;34(16):1898-904
pubmed: 27069086
Immune Netw. 2020 Aug 04;20(4):e29
pubmed: 32895616
Int J Mol Sci. 2018 Nov 05;19(11):
pubmed: 30400561
Anticancer Res. 2015 Jul;35(7):4191-6
pubmed: 26124377
Am J Clin Oncol. 2018 Aug;41(8):766-771
pubmed: 28079594
Parasitology. 2020 Nov;147(13):1425-1432
pubmed: 32729453
Cell Rep. 2013 Jul 25;4(2):287-301
pubmed: 23850289
Science. 2005 Dec 9;310(5754):1642-6
pubmed: 16308421
Clin Transl Med. 2018 Mar 1;7(1):11
pubmed: 29541939
Ther Adv Respir Dis. 2012 Apr;6(2):107-14
pubmed: 22333982
Proc Natl Acad Sci U S A. 2015 Feb 10;112(6):1809-14
pubmed: 25624476
J Biol Chem. 2000 Jan 7;275(1):223-8
pubmed: 10617608